News

Blueprint Medicines Presents Strong Long-Term Data for AYVAKIT in Systemic Mastocytosis
Blueprint Medicines Corporation (NASDAQ: BPMC) is one of the best biotech stocks to invest in now. On June 12, Blueprint ...
BioWorld6d
Blueprint Medicines describes new CDK2 degradation inducers
Blueprint Medicines Corp. has identified proteolysis targeting chimera (PROTAC) compounds comprising an E3 ubiquitin ligase-binding moiety covalently linked to a cyclin dependent kinase 2 ...
Scientists propose blueprint for 'universal translator' in quantum networks
UBC researchers are proposing a solution to a key hurdle in quantum networking: a device that can "translate" microwave to ...
STAT6d
Cogent Biosciences-Blueprint Medicines tiff turns spicy on eve of immune drug study readout
During a talk at the recent Jefferies Global Healthcare Conference, Cogent CEO Andy Robbins said Blueprint Medicines’ Ayvakit ...